Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart L Fine
Daniel F Martin
Peter Kirkpatrick

Showing results (31-40 of 252) with videos related to

Pageof 26
Sort By:
Retina (Philadelphia, Pa.)|July 29, 2005
Histopathologic features of idiopathic macular holes and cysts. 1990David R Guyer, W Richard Green, Serge de Bustros, et al.
Nature Reviews. Drug Discovery|March 11, 2005
NatalizumabJohn H Noseworthy, Peter Kirkpatrick
Nature Reviews. Drug Discovery|November 24, 2004
Duloxetine hydrochlorideAnathea B Waitekus, Peter Kirkpatrick
Nature Reviews. Drug Discovery|June 18, 2005
PregabalinRobert H Dworkin, Peter Kirkpatrick
Ophthalmology|October 14, 2014
Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)Michael M Altaweel, Ebenezer Daniel, Daniel F Martin, et al.
American Journal of Ophthalmology|January 18, 2018
Evolution of Intravitreal Therapy for Retinal Diseases-From CMV to CNV: The LXXIV Edward Jackson Memorial LectureDaniel F Martin
Nature Reviews. Drug Discovery|March 7, 2003
EplerenoneRuth Brown, Jeremy Quirk, Peter Kirkpatrick
Nature Reviews. Drug Discovery|December 2, 2010
VernakalantDobromir Dobrev, Bashar Hamad, Peter Kirkpatrick
Nature Reviews. Drug Discovery|June 1, 2007
Lisdexamfetamine dimesylateJosephine Elia, Chris Easley, Peter Kirkpatrick
Nature Reviews. Drug Discovery|August 19, 2006
Quadrivalent human papillomavirus recombinant vaccineChristopher Crum, Carole Jones, Peter Kirkpatrick
Pageof 26

Showing results (31-40 of 252) with videos related to

Sort By:
Pageof 26
Retina (Philadelphia, Pa.)|July 29, 2005
Histopathologic features of idiopathic macular holes and cysts. 1990David R Guyer, W Richard Green, Serge de Bustros, et al.
Nature Reviews. Drug Discovery|March 11, 2005
NatalizumabJohn H Noseworthy, Peter Kirkpatrick
Nature Reviews. Drug Discovery|November 24, 2004
Duloxetine hydrochlorideAnathea B Waitekus, Peter Kirkpatrick
Nature Reviews. Drug Discovery|June 18, 2005
PregabalinRobert H Dworkin, Peter Kirkpatrick
Ophthalmology|October 14, 2014
Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)Michael M Altaweel, Ebenezer Daniel, Daniel F Martin, et al.
American Journal of Ophthalmology|January 18, 2018
Evolution of Intravitreal Therapy for Retinal Diseases-From CMV to CNV: The LXXIV Edward Jackson Memorial LectureDaniel F Martin
Nature Reviews. Drug Discovery|March 7, 2003
EplerenoneRuth Brown, Jeremy Quirk, Peter Kirkpatrick
Nature Reviews. Drug Discovery|December 2, 2010
VernakalantDobromir Dobrev, Bashar Hamad, Peter Kirkpatrick
Nature Reviews. Drug Discovery|June 1, 2007
Lisdexamfetamine dimesylateJosephine Elia, Chris Easley, Peter Kirkpatrick
Nature Reviews. Drug Discovery|August 19, 2006
Quadrivalent human papillomavirus recombinant vaccineChristopher Crum, Carole Jones, Peter Kirkpatrick
Pageof 26